Fractyl Health, Inc. 8-K Summary
Business Context and Reporting Period
This Form 8-K reports on the 2026 Annual Meeting of Stockholders held by Fractyl Health, Inc. on June 10, 2026. The company is incorporated in Delaware and trades on The Nasdaq Global Market under the symbol GUTS.
Key Financial Metrics
The filing text does not provide a clear value for revenue, profit, cash flow, margins, debt, or liquidity. This report focuses exclusively on corporate governance matters and voting results.
Material Changes and Voting Results
Of the 158,648,963 shares outstanding as of the April 17, 2026 record date, 112,236,206 shares (approximately 70.7% of voting power) were represented at the meeting. The following matters were approved:
- Election of Class II Directors: Marc Elia, Clive Meanwell, M.B., Ch.B., M.D., and Ian Sheffield were elected for three-year terms ending in 2029.
- Ratification of Independent Auditors: Ernst & Young LLP was ratified as the independent registered public accounting firm for the fiscal year ending December 31, 2026.
Guidance, Outlook, and Risks
The filing text does not provide a clear value for guidance, outlook, management commentary, risks, contingencies, or unusual items.
Investor Verification Checklist
- Verify the definitive proxy statement filed on April 24, 2026, for detailed biographies of the newly elected directors.
- Confirm the total number of shares outstanding and voting power calculations in the company's subsequent quarterly filings.
- Review the company's upcoming 10-K or 10-Q for the first disclosure of financial performance metrics for the 2026 fiscal year.